These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20875294)

  • 41. Mixtures of oseltamivir-sensitive and -resistant pandemic influenza A/H1N1/2009 viruses in immunocompromised hospitalized children.
    Suhaila M; Tang JW; Lee HK; Lin C; Tambyah PA; Yap HK; Quak SH; Koay ES
    Pediatr Infect Dis J; 2011 Jul; 30(7):625-7. PubMed ID: 21206398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase.
    van der Vries E; Jonges M; Herfst S; Maaskant J; Van der Linden A; Guldemeester J; Aron GI; Bestebroer TM; Koopmans M; Meijer A; Fouchier RA; Osterhaus AD; Boucher CA; Schutten M
    J Clin Virol; 2010 Jan; 47(1):34-7. PubMed ID: 19857993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Update on oseltamivir-resistant pandemic A (H1N1) 2009 influenza virus: January 2010.
    Wkly Epidemiol Rec; 2009 Feb; 85(6):37-40. PubMed ID: 20151493
    [No Abstract]   [Full Text] [Related]  

  • 44. A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.
    Matsuzaki Y; Mizuta K; Aoki Y; Suto A; Abiko C; Sanjoh K; Sugawara K; Takashita E; Itagaki T; Katsushima Y; Ujike M; Obuchi M; Odagiri T; Tashiro M
    Virol J; 2010 Mar; 7():53. PubMed ID: 20202225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China.
    Huang W; Li X; Cheng Y; Tan M; Guo J; Wei H; Zhao X; Lan Y; Xiao N; Wang Z; Wang D; Shu Y
    Virol J; 2015 Jun; 12():96. PubMed ID: 26103966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
    Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
    J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of an oseltamivir-resistant pandemic influenza A/H1N1 virus in Hong Kong.
    Leung TW; Tai AL; Cheng PK; Kong MS; Lim W
    J Clin Virol; 2009 Nov; 46(3):298-9. PubMed ID: 19736041
    [No Abstract]   [Full Text] [Related]  

  • 48. Antiviral drug susceptibilities of seasonal human influenza viruses in Lebanon, 2008-09 season.
    Zaraket H; Saito R; Wakim R; Tabet C; Medlej F; Reda M; Baranovich T; Suzuki Y; Dapat C; Caperig-Dapat I; Dbaibo GS; Suzuki H
    J Med Virol; 2010 Jul; 82(7):1224-8. PubMed ID: 20513088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia.
    Hurt AC; Hardie K; Wilson NJ; Deng YM; Osbourn M; Leang SK; Lee RT; Iannello P; Gehrig N; Shaw R; Wark P; Caldwell N; Givney RC; Xue L; Maurer-Stroh S; Dwyer DE; Wang B; Smith DW; Levy A; Booy R; Dixit R; Merritt T; Kelso A; Dalton C; Durrheim D; Barr IG
    J Infect Dis; 2012 Jul; 206(2):148-57. PubMed ID: 22561367
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oseltamivir-resistant influenza A(H1N1)pdm09 viruses, United States, 2013-14.
    Okomo-Adhiambo M; Fry AM; Su S; Nguyen HT; Elal AA; Negron E; Hand J; Garten RJ; Barnes J; Xiyan X; Villanueva JM; Gubareva LV;
    Emerg Infect Dis; 2015 Jan; 21(1):136-41. PubMed ID: 25532050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A/H1N1 viruses.
    Zaraket H; Saito R; Suzuki Y; Baranovich T; Dapat C; Caperig-Dapat I; Suzuki H
    J Clin Microbiol; 2010 Apr; 48(4):1085-92. PubMed ID: 20129961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. H1N1 influenza A virus neuraminidase modulates infectivity in mice.
    Ferraris O; Escuret V; Bouscambert M; Casalegno JS; Jacquot F; Raoul H; Caro V; Valette M; Lina B; Ottmann M
    Antiviral Res; 2012 Mar; 93(3):374-80. PubMed ID: 22321413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States.
    Graitcer SB; Gubareva L; Kamimoto L; Doshi S; Vandermeer M; Louie J; Waters C; Moore Z; Sleeman K; Okomo-Adhiambo M; Marshall SA; St George K; Pan CY; LaPlante JM; Klimov A; Fry AM
    Emerg Infect Dis; 2011 Feb; 17(2):255-7. PubMed ID: 21291599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oseltamivir- and amantadine-resistant influenza viruses A (H1N1).
    Cheng PK; Leung TW; Ho EC; Leung PC; Ng AY; Lai MY; Lim WW
    Emerg Infect Dis; 2009 Jun; 15(6):966-8. PubMed ID: 19523305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009.
    Chen LF; Dailey NJ; Rao AK; Fleischauer AT; Greenwald I; Deyde VM; Moore ZS; Anderson DJ; Duffy J; Gubareva LV; Sexton DJ; Fry AM; Srinivasan A; Wolfe CR
    J Infect Dis; 2011 Mar; 203(6):838-46. PubMed ID: 21343149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus.
    Gooskens J; Jonges M; Claas EC; Meijer A; van den Broek PJ; Kroes AM
    JAMA; 2009 Mar; 301(10):1042-6. PubMed ID: 19255111
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel influenza A(H1N1) 2009 in vitro reassortant viruses with oseltamivir resistance.
    Ottmann M; Duchamp MB; Casalegno JS; Frobert E; Moulès V; Ferraris O; Valette M; Escuret V; Lina B
    Antivir Ther; 2010; 15(5):721-6. PubMed ID: 20710053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
    Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
    J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009.
    Wkly Epidemiol Rec; 2009 Oct; 84(44):453-9. PubMed ID: 19894344
    [No Abstract]   [Full Text] [Related]  

  • 60. Zanamivir-resistant influenza viruses with a novel neuraminidase mutation.
    Hurt AC; Holien JK; Parker M; Kelso A; Barr IG
    J Virol; 2009 Oct; 83(20):10366-73. PubMed ID: 19641000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.